American Psychological Association 6th edition

Ashaq, M. S., Zhou, Q., Li, Y., Guo, M., Zhang, S., Wang, L., Li, Z., Wang, Y., Huang, Y., Shi, Z., Li, Y., & Zhao, B. (2026). Integrative transcriptomics defines CD36 as a key regulator of immunometabolic signaling in acute myeloid leukemia. Genes & Genomics, 1-21. https://doi.org/10.1007/s13258-025-01728-6

ISO-690 (author-date, English)

ASHAQ, Muhammad Sameer, ZHOU, Qian, LI, Yanxia, GUO, Meiqi, ZHANG, Shujing, WANG, Lingling, LI, Zhuoran, WANG, Yi, HUANG, Yufeng, SHI, Zhida, LI, Yuan and ZHAO, Baobing, 2026. Integrative transcriptomics defines CD36 as a key regulator of immunometabolic signaling in acute myeloid leukemia. Genes & Genomics. 5 January 2026. P. 1-21. DOI 10.1007/s13258-025-01728-6.

Modern Language Association 9th edition

Ashaq, M. S., Q. Zhou, Y. Li, M. Guo, S. Zhang, L. Wang, Z. Li, Y. Wang, Y. Huang, Z. Shi, Y. Li, and B. Zhao. “Integrative Transcriptomics Defines CD36 As a Key Regulator of Immunometabolic Signaling in Acute Myeloid Leukemia”. Genes & Genomics, Jan. 2026, pp. 1-21, https://doi.org/10.1007/s13258-025-01728-6.

Mohr Siebeck - Recht (Deutsch - Österreich)

Ashaq, Muhammad Sameer/Zhou, Qian/Li, Yanxia/Guo, Meiqi/Zhang, Shujing/Wang, Lingling et al.: Integrative transcriptomics defines CD36 as a key regulator of immunometabolic signaling in acute myeloid leukemia, Genes & Genomics 2026, 1-21.

Emerald - Harvard

Ashaq, M.S., Zhou, Q., Li, Y., Guo, M., Zhang, S., Wang, L., Li, Z., Wang, Y., Huang, Y., Shi, Z., Li, Y. and Zhao, B. (2026), “Integrative transcriptomics defines CD36 as a key regulator of immunometabolic signaling in acute myeloid leukemia”, Genes & Genomics, pp. 1-21.

Warning: These citations may not always be 100% accurate.